The largest database of trusted experimental protocols

7 protocols using pimozide

1

Inhibitor-based Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Imatinib was purchased from LC Laboratories. Stock solutions were prepared in sterile water at 10 mmol/L and stored at −20°C. Small molecule inhibitor of DUSP6 (2-benzylidene-3-(cyclohexylamino)-1-lndanone hydrochloride; BCI) and the ABL1 activator DPH were purchased from Sigma-Aldrich. BCI-215 was a gift from Dr. Andreas Vogt. The MEK inhibitor (trametinib), the JAK inhibitor (ruxolitinib) and ponatinib were purchased from LC Laboratories. Pimozide (STAT5 inhibitor) was purchased from TOCRIS. Stock solutions were prepared in DMSO at 10 mmol/L and stored at −20°C. For in vivo experiments, compounds were dissolved in NMP:PEG300 (1:9). Ph-like ALL cells (Fig 2e) were treated with ruxolitinib for 20 hours and then processed for Western blotting.
+ Open protocol
+ Expand
2

Diubiquitin Topoisomer Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitin monomer, BSA, Tris and DTT were purchased from Sigma-Aldrich. Diubiquitin topoisomers (M1, K6, K11, K27, K29, K33, K48 and K63-linked) were purchased from Boston Biochem (Boston, MA), additional K27 diubiquitin was produced in-house57 (link)58 , whereas all MALDI-TOF MS materials (targets, matrix and protein calibration mixture) were purchased from Bruker Daltonics (Bremen, Germany). PR-619 and P22077 (Calbiochem/Merck, Darmstadt, Germany) as well as HBX 41,108, pimozide and degrasyn/WP1130 (Tocris Bioscience, Bristol, UK) and L434078 (Sigma-Aldrich, St Louis, MO, USA) were purchased commercially. Febuxostat, SJB3-019A, compound 16, NSC 697923 and BAY 11-7082 were synthesized (Supplementary Table 3).
+ Open protocol
+ Expand
3

Cytokine and Drug Treatment of BAL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BAL cells were pelleted, washed and cultured in the medium (RPMI 1640 plus 10% FBS) alone or with cytokines (as described for PBMCs in the previous section) with vehicle (0.1% DMSO) or Dexamethasone (10−7 M, from Sigma-Aldrich, Inc. St. Louis, MO). In select experiments Trametinib (10 μM) from LC Laboratories, Tofacitinib (0.2 μM) from ApexBio, or Pimozide (5 μM) from Tocris Bioscience was added to the culture. BAL cells were cultured for 3 days until otherwise stated. Monensin (2 μM) was added to all cultures 4 hr before conclusion. Following culture cells were pelleted and then stained for flow cytometry as described previously (7 (link), 15 (link)).
+ Open protocol
+ Expand
4

Evaluation of Antidepressant Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluoxetine (#H6995, Bosche Scientific), citalopram (#C505000, Toronto Research Chemicals), paroxetine (#2141, Tocris), fluvoxamine (#1033), venlafaxine (#2917, Tocris), reboxetine (#1982, Tocris), imipramine (#I7379-5G, Sigma–Aldrich), clomipramine (#C7291, Sigma–Aldrich), desipramine (#3067, Tocris), phenelzine (#P6777, Sigma–Aldrich), rolipram (#R6520, Sigma–Aldrich), ketamine (#3131, Tocris), 2R, 6R-Hydroxynorketamine and 2S, 6S-Hydroxynorketamine (#6094 and #6095, respectively, Tocris), carbamazepine (#4098, Tocris), chlorpromazine (#C8138, Sigma–Aldrich), flupenthixol (#4057, Tocris), and pimozide (#0937, Tocris) were investigated in this study. The compounds were dissolved in dimethyl sulfoxide (DMSO) that was also used as a vehicle in all the experiments. Concentrations tested (Table 1) were selected based on earlier in vitro studies from our research group (Fred et al., 2019 (link); Casarotto et al., 2021 (link)) and other laboratories (Johansen et al., 2015 (link)).
+ Open protocol
+ Expand
5

Quantitative Analysis of Diubiquitin Linkages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitin monomer, Bovine Serum Albumin (BSA), Tris and DTT were purchased from Sigma Aldrich. Diubiquitin topoisomers (M1, K6, K11, K27, K29, K33, K48 and K63-linked) were purchased from Boston Biochem (Boston, MA), additional K27 diubiquitin was produced in-house57 (link), 58 (link), whereas all MALDI-TOF MS materials (targets, matrix and protein calibration mixture) were purchased from Bruker Daltonics (Bremen, Germany). PR-619 and P22077 (Calbiochem/Merck, Darmstadt, Germany) as well as HBX 41,108, Pimozide and Degrasyn/WP1130 (Tocris Bioscience, Bristol, UK) and L434078 (Sigma-Aldrich, St. Louis, MO, USA) were purchased commercially. Febuxostat, SJB3-019A, Compound 16, NSC 697923 and BAY 11-7082 were synthesized (Supplementary Table 3).
+ Open protocol
+ Expand
6

Small Molecule Screening Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
All-trans retinal, fibronectin, amitriptyline hydrochloride, nicardipine, amlodipine besylate, diltiazem hydrochloride, and verapamil were from Sigma Aldrich (St. Louis, MO). Mibefradil was from Alomone Labs (Jerusalem, Israel). Pimozide was from Tocris Bioscience (Bristol, UK).
+ Open protocol
+ Expand
7

Inhibitor-based Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Imatinib was purchased from LC Laboratories. Stock solutions were prepared in sterile water at 10 mmol/L and stored at −20°C. Small molecule inhibitor of DUSP6 (2-benzylidene-3-(cyclohexylamino)-1-lndanone hydrochloride; BCI) and the ABL1 activator DPH were purchased from Sigma-Aldrich. BCI-215 was a gift from Dr. Andreas Vogt. The MEK inhibitor (trametinib), the JAK inhibitor (ruxolitinib) and ponatinib were purchased from LC Laboratories. Pimozide (STAT5 inhibitor) was purchased from TOCRIS. Stock solutions were prepared in DMSO at 10 mmol/L and stored at −20°C. For in vivo experiments, compounds were dissolved in NMP:PEG300 (1:9). Ph-like ALL cells (Fig 2e) were treated with ruxolitinib for 20 hours and then processed for Western blotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!